Biomarker expression and druggable gene alterations for development of an appropriate therapeutic protocol for pulmonary adenosquamous carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|66|7|939-948

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.66, Iss.7, 2015-06, pp. : 939-948

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenosquamous Carcinoma of the Esophagus

By  

Oncology, Vol. 66, Iss. 3, 2004-06 ,pp. : 218-225

Karger

Access to resources Recommend Favorite

Epigenetic and Genetic Alterations of the EDNRB Gene in Nasopharyngeal Carcinoma

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 357-363

Karger

Access to resources Recommend Favorite

Paired boxed gene 1 expression: A single potential biomarker for differentiating endometrial lesions associated with favorable outcomes in patients with endometrial carcinoma

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 42, Iss. 9, 2016-09 ,pp. : 1159-1167

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alterations of Deadenylase Expression in Acute Leukemias: Evidence for Poly(A)-Specific Ribonuclease as a Potential Biomarker

By  

Acta Haematologica, Vol. 128, Iss. 1, 2012-05 ,pp. : 39-46

Karger

Access to resources Recommend Favorite

Primary Adenosquamous and Squamous Cell Carcinoma of the Upper Urinary Tract

By  

Urologia Internationalis, Vol. 64, Iss. 1, 2000-04 ,pp. : 47-51

Karger

Access to resources Recommend Favorite